BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21071923)

  • 21. Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells.
    Kim YS; Ahn Y; Hong MH; Joo SY; Kim KH; Sohn IS; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):41-9. PubMed ID: 17666914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development.
    Teesalu T; Blasi F; Talarico D
    Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of vacuum-assisted closure on the expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in acute and chronic wounds healing].
    Li YJ; Cao DY; Chen SZ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2006 Jul; 22(4):306-9. PubMed ID: 17017150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
    Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
    Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
    Whitley BR; Church FC
    Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JNK MAPK signaling contributes in vivo to injury-induced corneal epithelial migration.
    Okada Y; Saika S; Shirai K; Yamanaka O; Kitano A; Wang Z; Yang H; Reinach P
    Ophthalmic Res; 2009; 42(4):185-92. PubMed ID: 19672126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of the urokinase plasminogen activator system by oncostatin M promotes endothelial migration.
    Strand K; Murray J; Aziz S; Ishida A; Rahman S; Patel Y; Cardona C; Hammond WP; Savidge G; Wijelath ES
    J Cell Biochem; 2000 Aug; 79(2):239-48. PubMed ID: 10967551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis.
    Camacho-Barquero L; Villegas I; Sánchez-Calvo JM; Talero E; Sánchez-Fidalgo S; Motilva V; Alarcón de la Lastra C
    Int Immunopharmacol; 2007 Mar; 7(3):333-42. PubMed ID: 17276891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel function of extraerythrocytic hemoglobin: identification of globin as a stimulant of plasminogen activator biosynthesis in human fibroblasts.
    Yoshida E; Ohmura S; Sugiki M; Anai K; Maruyama M
    Thromb Haemost; 2001 Dec; 86(6):1521-7. PubMed ID: 11776322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated platelets increase fibrinolysis of mesenchymal progenitor cells.
    Agis H; Kandler B; Fischer MB; Watzek G; Gruber R
    J Orthop Res; 2009 Jul; 27(7):972-80. PubMed ID: 19030175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
    Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. uPA dependent and independent mechanisms of wound healing by C-phycocyanin.
    Madhyastha HK; Radha KS; Nakajima Y; Omura S; Maruyama M
    J Cell Mol Med; 2008 Dec; 12(6B):2691-703. PubMed ID: 18266963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin.
    Yoshida E; Verrusio EN; Mihara H; Oh D; Kwaan HC
    Cancer Res; 1994 Jun; 54(12):3300-4. PubMed ID: 8205553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MEKK1 is required for inducible urokinase-type plasminogen activator expression.
    Witowsky J; Abell A; Johnson NL; Johnson GL; Cuevas BD
    J Biol Chem; 2003 Feb; 278(8):5941-6. PubMed ID: 12493778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase.
    Kocić J; Santibañez JF; Krstić A; Mojsilović S; Ilić V; Bugarski D
    Int J Biochem Cell Biol; 2013 Feb; 45(2):464-75. PubMed ID: 23183001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Involvement of urokinase and its receptor in the remodeling of normal and pathological tissue].
    Tkachuk VA; Stepanova VV; Volynskaia EA
    Vestn Ross Akad Med Nauk; 1998; (8):36-41. PubMed ID: 9771129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin intervention during progressive fibrosis controls inflammatory cytokines and the fibrinolytic system in pulmonary fibrosis.
    Fathimath Muneesa M; Barki RR; Shaikh SB; Bhandary YP
    Toxicol Appl Pharmacol; 2022 Aug; 449():116116. PubMed ID: 35716765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel inhibits transforming growth factor-β-increased urokinase-type plasminogen activator expression through p38 MAPK and RAW 264.7 macrophage migration.
    Mojsilovic S; Tosic M; Mojsilovic S; Zivanovic M; Bjelica S; Srdic Rajic T; F Santibanez J
    J BUON; 2020; 25(2):1257-1265. PubMed ID: 32521934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of urokinase plasminogen activator on cultured human retinal epithelial cells].
    Boiko EV; Mal'tsev DS; Polyakova VO
    Vestn Oftalmol; 2017; 133(1):42-48. PubMed ID: 28291199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.